by Urška Mrgole | Feb 27, 2026 | News
The EANM 2025 congress in Barcelona (Spain) confirmed that nuclear medicine is moving from rapid expansion into a phase of consolidation, shaped by theranostics, isotope availability, and translation into routine clinical use. With nearly 10,000 participants from more...
by Urška Mrgole | Feb 24, 2026 | News
Putting patients, prevention, and public trust at the heart of cancer care, the Cyprus Association of Cancer Patients & Friends (PASYKAF) has been a key advocate for people affected by cancer for decades, both nationally and internationally. PASYKAF is a...
by Urška Mrgole | Feb 19, 2026 | News
Cosylab d.d. supports cutting-edge accelerator-based technologies worldwide—from Big Science facilities to advanced medical applications—and brings this same end-to-end expertise to IFIGENEIA’s work on radioisotope production and radiopharmaceuticals. Cosylab d.d. is...
by Urška Mrgole | Feb 16, 2026 | Events, News
IFIGENEIA is proud to be an organiser of a ten-day event, a challenge based on innovations for students – CBI, that will be held at the University of Sarajevo. The goal is to present an innovative idea on the use of accelerators in applications that benefit the...
by Urška Mrgole | Feb 13, 2026 | News
The IFIGENEIA project (Horizon Europe, WIDERA) aims to lay the foundations for significant advancements in the production and clinical application of radionuclides using linear accelerators (LINACs), thereby enhancing radiopharmaceutical development and availability...
